Annual Financials for Caribou Biosciences Inc.
Assets
Fiscal year is January-December. All values USD millions. |
| 2019 | 2020 | 2021 | 2022 |
5-year trend |
Cash & Short Term Investments |
- | 41.07M | 15.95M | 375.83M | 247.66M | |
Cash Only |
- | 41.07M | 15.95M | 240.42M | 58.34M | |
Short-Term Investments |
- | - | - | - | - | |
Cash & Short Term Investments Growth |
- | - | -61.16% | 2,255.87% | -34.10% | |
Cash & ST Investments / Total Assets |
- | 66.31% | 41.40% | 84.42% | 64.45% | |
Total Accounts Receivable |
- | 3.98M | 5.16M | 8.12M | 4.66M | |
Accounts Receivables, Net |
- | 841,000 | 1.48M | 2.64M | 2.45M | |
Accounts Receivables, Gross |
- | 841,000 | 1.48M | 2.64M | 2.45M | |
Bad Debt/Doubtful Accounts |
- | - | - | - | - | |
Other Receivables |
- | 3.14M | 3.68M | 5.48M | 2.22M | |
Accounts Receivable Growth |
- | - | 29.58% | 57.44% | -42.59% | |
Accounts Receivable Turnover |
- | 1.45 | 2.40 | 1.18 | 2.97 | |
Inventories |
- | - | - | - | - | |
Finished Goods |
- | - | - | - | - | |
Work in Progress |
- | - | - | - | - | |
Raw Materials |
- | - | - | - | - | |
Progress Payments & Other |
- | - | - | - | - | |
Other Current Assets |
- | 11.96M | 3.19M | 7.24M | 7.92M | |
Miscellaneous Current Assets |
- | 8.77M | 760,000 | 671,000 | 1.12M | |
Total Current Assets |
- | 57.01M | 24.31M | 391.19M | 260.25M | |
|
| 2019 | 2020 | 2021 | 2022 |
5-year trend |
Net Property, Plant & Equipment |
- | 4.33M | 3.5M | 4.89M | 34.91M | |
Property, Plant & Equipment - Gross |
- | 6.59M | 6.6M | 8.96M | 40.56M | |
Buildings |
- | - | - | - | - | |
Land & Improvements |
- | - | - | - | - | |
Computer Software and Equipment |
- | 261,000 | 263,000 | 273,000 | 709,000 | |
Other Property, Plant & Equipment |
- | 1.26M | 1.3M | 1.83M | 2.04M | |
Accumulated Depreciation |
- | 2.26M | 3.1M | 4.08M | 5.65M | |
Total Investments and Advances |
- | - | 7.63M | 45.4M | 77.07M | |
Other Long-Term Investments |
- | - | 7.63M | 45.4M | 77.07M | |
Long-Term Note Receivable |
- | - | - | - | - | |
Intangible Assets |
- | - | - | - | - | |
Net Goodwill |
- | - | - | - | - | |
Net Other Intangibles |
- | - | - | - | - | |
Other Assets |
- | 593,000 | 612,000 | 875,000 | 1.54M | |
Tangible Other Assets |
- | 593,000 | 612,000 | 875,000 | 1.54M | |
Total Assets |
- | 61.93M | 38.53M | 445.2M | 384.27M | |
Assets - Total - Growth |
- | - | -37.79% | 1,055.47% | -13.69% | |
Liabilities & Shareholders' Equity
|
| 2019 | 2020 | 2021 | 2022 |
5-year trend |
ST Debt & Current Portion LT Debt |
- | 532,000 | 847,000 | 259,000 | 966,000 | |
Short Term Debt |
- | 532,000 | 193,000 | 259,000 | 966,000 | |
Current Portion of Long Term Debt |
- | - | 654,000 | - | - | |
Accounts Payable |
- | 2.54M | 2.6M | 3.99M | 1.15M | |
Accounts Payable Growth |
- | - | 2.52% | 53.40% | -71.28% | |
Income Tax Payable |
- | 11,000 | 5,000 | - | - | |
Other Current Liabilities |
- | 7M | 8.94M | 21.58M | 26.02M | |
Dividends Payable |
- | - | - | - | - | |
Accrued Payroll |
- | 400,000 | 2.08M | 4.23M | - | |
Miscellaneous Current Liabilities |
- | 6.6M | 6.86M | 17.36M | 26.02M | |
Total Current Liabilities |
- | 10.08M | 12.39M | 25.83M | 28.13M | |
Long-Term Debt |
- | 41.32M | 42.25M | - | 26.78M | |
Long-Term Debt excl. Capitalized Leases |
- | 41.32M | 42.25M | - | - | |
Non-Convertible Debt |
- | 41.32M | 42.25M | - | - | |
Convertible Debt |
- | - | - | - | - | |
Capitalized Lease Obligations |
- | - | - | - | - | |
Provision for Risks & Charges |
- | - | - | - | - | |
Deferred Taxes |
- | 650,000 | 155,000 | 476,000 | 381,000 | |
Deferred Taxes - Credit |
- | 650,000 | 2.64M | 3.32M | 10.88M | |
Deferred Taxes - Debit |
- | - | 2.48M | 2.85M | 10.5M | |
Other Liabilities |
- | 2.42M | 4.69M | 28.23M | 17.61M | |
Other Liabilities (excl. Deferred Income) |
- | 1.43M | 3.76M | 6.19M | 1.65M | |
Deferred Income |
- | 986,000 | 937,000 | 22.03M | 15.95M | |
Total Liabilities |
- | 54.47M | 61.97M | 57.38M | 83.4M | |
Non-Equity Reserves |
- | - | - | - | - | |
Total Liabilities / Total Assets |
- | 87.95% | 160.83% | 12.89% | 21.70% | |
Preferred Stock (Carrying Value) |
- | - | - | - | - | |
Redeemable Preferred Stock |
- | - | - | - | - | |
Non-Redeemable Preferred Stock |
- | - | - | - | - | |
Common Equity (Total) |
- | 7.46M | (23.44M) | 387.83M | 300.87M | |
Common Stock Par/Carry Value |
- | 1,000 | 1,000 | 6,000 | 6,000 | |
Retained Earnings |
- | 3.44M | (30.87M) | (97.79M) | (197.22M) | |
ESOP Debt Guarantee |
- | - | - | - | - | |
Cumulative Translation Adjustment/Unrealized For. Exch. Gain |
- | - | - | - | - | |
Unrealized Gain/Loss Marketable Securities |
- | - | - | (135,000) | (1.52M) | |
Revaluation Reserves |
- | - | - | - | - | |
Treasury Stock |
- | - | - | - | - | |
Common Equity / Total Assets |
- | 12.05% | -60.83% | 87.11% | 78.30% | |
Total Shareholders' Equity |
- | 7.46M | (23.44M) | 387.83M | 300.87M | |
Total Shareholders' Equity / Total Assets |
- | 12.05% | -60.83% | 87.11% | 78.30% | |
Accumulated Minority Interest |
- | - | - | - | - | |
Total Equity |
- | 7.46M | (23.44M) | 387.83M | 300.87M | |
Liabilities & Shareholders' Equity |
- | 61.93M | 38.53M | 445.2M | 384.27M | |